Ascendis Pharma A (ASND) Cash from Operations (2014 - 2026)
Ascendis Pharma A's Cash from Operations was $327.42 million in the quarter ended Jun 30, 2026, compared with -$8.31 million a year earlier.
Powered by 
Analysis
Ascendis Pharma A (ASND) Cash from Operations (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ascendis Pharma A's Cash from Operations was $197.19 million through Jun 30, 2026; for the year ended Dec 31, 2025, it was -$142.1 million.
- In earlier years, Cash from Operations was -$331.41 million in the year ended Dec 31, 2024, -$505.55 million in the year ended Dec 31, 2023, -$522.44 million in the year ended Dec 31, 2022 and -$477.78 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Cash from Operations in data going back to the quarter ended Mar 31, 2014.
- Per Business Quant data, ASND's Cash from Operations in the three quarters before the quarter ended Jun 30, 2026 was -$9.04 million (quarter ended Mar 31, 2026), -$123.7 million (quarter ended Dec 31, 2025) and $2.52 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 10.69 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 7.72 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 3.44 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 5.37 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 5.88 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 2.87 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 4.00 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.57 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 835.00 Mn |
| 10 | Ascendis Pharma A | 15.06 Bn | 11.32 Bn | 362.22 Mn | 327.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 327.42 Mn |
| Mar 31, 2026 | -9.04 Mn |
| Dec 31, 2025 | 85.44 Mn |
| Sep 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | -8.31 Mn |
| Mar 31, 2025 | -15.06 Mn |
| Dec 31, 2024 | -93.16 Mn |
| Sep 30, 2024 | -61.64 Mn |
| Jun 30, 2024 | -66.02 Mn |
| Mar 31, 2024 | -110.35 Mn |
| Dec 31, 2023 | -45.70 Mn |
| Sep 30, 2023 | -135.77 Mn |
| Jun 30, 2023 | -166.74 Mn |
| Mar 31, 2023 | -157.83 Mn |
| Dec 31, 2022 | -144.55 Mn |
| Sep 30, 2022 | -99.65 Mn |
| Jun 30, 2022 | -132.73 Mn |
| Mar 31, 2022 | -146.79 Mn |
| Dec 31, 2021 | -141.06 Mn |
| Sep 30, 2021 | -115.00 Mn |
API Access
Ascendis Pharma A Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();